Literature DB >> 16169662

Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.

Ying Huang1, Wolfgang Sadée.   

Abstract

Membrane transporters play important roles in mediating chemosensitivity and -resistance of tumor cells. ABC transporters, such as ABCB1/MDR1, ABCC1/MRP1 and ABCG2/BCRP, are frequently associated with decreased cellular accumulation of anticancer drugs and multidrug resistance of tumors. SLC transporters, such as folate, nucleoside, and amino acid transporters, commonly increase chemosensitivity by mediating the cellular uptake of hydrophilic drugs. Ion channels and pumps variably affect sensitivity to anticancer therapy by modulating viability of tumor cells. A pharmacogenomic approach, using correlations between drug potency and transporter gene expression in multiple cancer cell lines, has shown promise for identifying potential drug-transporter relationships and predicting anticancer drug response, in an effort to optimize chemotherapy for individual patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169662     DOI: 10.1016/j.canlet.2005.07.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  69 in total

1.  Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).

Authors:  Alexandra Orchard; Gregory A Schamerhorn; Brandon D Calitree; Geri A Sawada; Tip W Loo; M Claire Bartlett; David M Clarke; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2012-06-07       Impact factor: 3.641

Review 2.  Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Suresh V Ambudkar
Journal:  Curr Mol Pharmacol       Date:  2008-06       Impact factor: 3.339

3.  Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters.

Authors:  Mitsunori Okabe; Gergely Szakács; Mark A Reimers; Toshihiro Suzuki; Matthew D Hall; Takaaki Abe; John N Weinstein; Michael M Gottesman
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 4.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

5.  Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.

Authors:  Janet Morgan; Jennifer D Jackson; Xiang Zheng; Suresh K Pandey; Ravindra K Pandey
Journal:  Mol Pharm       Date:  2010-09-01       Impact factor: 4.939

Review 6.  Tackling breast cancer chemoresistance with nano-formulated siRNA.

Authors:  S K Jones; O M Merkel
Journal:  Gene Ther       Date:  2016-09-20       Impact factor: 5.250

7.  MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin.

Authors:  E Cecchin; G Perrone; S Nobili; J Polesel; E De Mattia; C Zanusso; P Petreni; S Lonardi; N Pella; M D'Andrea; D Errante; F Rizzolio; T Mazzei; I Landini; E Mini; G Toffoli
Journal:  Pharmacogenomics J       Date:  2014-10-21       Impact factor: 3.550

8.  Asymmetric ATP hydrolysis cycle of the heterodimeric multidrug ABC transport complex TmrAB from Thermus thermophilus.

Authors:  Ariane Zutz; Jan Hoffmann; Ute A Hellmich; Clemens Glaubitz; Bernd Ludwig; Bernd Brutschy; Robert Tampé
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

Review 9.  Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Authors:  Xue Xue; Matthew D Hall; Qiang Zhang; Paul C Wang; Michael M Gottesman; Xing-Jie Liang
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

10.  Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1.

Authors:  Ying Huang; Paul E Blower; Ruqing Liu; Zunyan Dai; Anh-Nhan Pham; Hojin Moon; Jialong Fang; Wolfgang Sadée
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.